Medical Network News March 16 According to the official website of the Bureau of Food and Drug Administration, since 2017, 77 products have entered the special approval channel of the General Administration of Administration of the People's Republic of China, involving 71 medical device companies. Among them, products for minimally invasive medical products have entered the special approval channel with the largest number of 6 products.
In addition, in terms of priority approval channels, there are 9 CFDA publicized products, involving 8 enterprise Among them, Guangzhou Wanfu Bio took 2 of them.
Form 1: Enter the special approval channel list:
Table 2: List of entering the priority approval channel
